HLB Life Science Co., Ltd. (067630.KQ)
KRW 6500.0
(3.17%)
KRW 6500.0
(3.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.98 Billion KRW | 88.98% |
| 2022 | -54.27 Billion KRW | -10.43% |
| 2021 | -49.15 Billion KRW | 11.91% |
| 2020 | -55.79 Billion KRW | -841.94% |
| 2019 | 7.52 Billion KRW | 141.34% |
| 2018 | -18.19 Billion KRW | -334.39% |
| 2017 | 7.76 Billion KRW | 720.22% |
| 2016 | -1.25 Billion KRW | 92.66% |
| 2015 | -17.04 Billion KRW | -1379.9% |
| 2014 | 1.33 Billion KRW | 129.95% |
| 2013 | -4.44 Billion KRW | 48.45% |
| 2012 | -8.62 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -144.43 Billion KRW | -199.55% |
| 2024 Q1 | 145.09 Billion KRW | 2148.72% |
| 2023 Q2 | -9.78 Billion KRW | -171.6% |
| 2023 Q4 | 6.45 Billion KRW | 139.55% |
| 2023 Q3 | -16.31 Billion KRW | -66.81% |
| 2023 FY | -5.98 Billion KRW | 88.98% |
| 2023 Q1 | 13.65 Billion KRW | 122.04% |
| 2022 Q2 | 6.59 Billion KRW | 163.61% |
| 2022 Q4 | -61.97 Billion KRW | -640.35% |
| 2022 Q3 | 11.46 Billion KRW | 73.91% |
| 2022 FY | -54.27 Billion KRW | -10.43% |
| 2022 Q1 | -10.36 Billion KRW | 83.9% |
| 2021 Q2 | -16.61 Billion KRW | -7.38% |
| 2021 Q4 | -64.39 Billion KRW | -236.04% |
| 2021 Q1 | -15.47 Billion KRW | 64.54% |
| 2021 Q3 | 47.33 Billion KRW | 384.87% |
| 2021 FY | -49.15 Billion KRW | 11.91% |
| 2020 Q2 | 1.49 Billion KRW | 105.88% |
| 2020 FY | -55.79 Billion KRW | -841.94% |
| 2020 Q4 | -43.64 Billion KRW | -471.91% |
| 2020 Q3 | 11.73 Billion KRW | 685.83% |
| 2020 Q1 | -25.38 Billion KRW | -259.0% |
| 2019 Q3 | -12.13 Billion KRW | -157.77% |
| 2019 Q2 | -4.7 Billion KRW | 29.93% |
| 2019 Q1 | -6.72 Billion KRW | 65.99% |
| 2019 FY | 7.52 Billion KRW | 141.34% |
| 2019 Q4 | 15.96 Billion KRW | 231.51% |
| 2018 Q4 | -19.76 Billion KRW | -82462.02% |
| 2018 Q3 | 23.99 Million KRW | -99.13% |
| 2018 Q2 | 2.76 Billion KRW | 326.32% |
| 2018 Q1 | -1.22 Billion KRW | -114.62% |
| 2018 FY | -18.19 Billion KRW | -334.39% |
| 2017 Q1 | -142.6 Million KRW | -112.18% |
| 2017 Q3 | -299.44 Million KRW | -82.32% |
| 2017 Q4 | 8.36 Billion KRW | 2894.23% |
| 2017 Q2 | -164.24 Million KRW | -15.17% |
| 2017 FY | 7.76 Billion KRW | 720.22% |
| 2016 Q3 | -1.76 Billion KRW | -309.04% |
| 2016 Q4 | 1.17 Billion KRW | 166.15% |
| 2016 FY | -1.25 Billion KRW | 92.66% |
| 2016 Q2 | -432.6 Million KRW | -96.8% |
| 2016 Q1 | -219.81 Million KRW | 96.06% |
| 2015 Q1 | -1.35 Billion KRW | -240.26% |
| 2015 Q2 | -7.45 Billion KRW | -449.72% |
| 2015 Q4 | -5.58 Billion KRW | -110.87% |
| 2015 Q3 | -2.64 Billion KRW | 64.51% |
| 2015 FY | -17.04 Billion KRW | -1379.9% |
| 2014 Q1 | -69.53 Million KRW | 96.45% |
| 2014 Q2 | 264 Million KRW | 479.69% |
| 2014 FY | 1.33 Billion KRW | 129.95% |
| 2014 Q3 | 169.77 Million KRW | -35.69% |
| 2014 Q4 | 967.18 Million KRW | 469.7% |
| 2013 Q2 | -1.28 Billion KRW | -135.12% |
| 2013 Q3 | -651.87 Million KRW | 49.35% |
| 2013 Q4 | -1.95 Billion KRW | -200.58% |
| 2013 FY | -4.44 Billion KRW | 48.45% |
| 2013 Q1 | -547.33 Million KRW | 91.03% |
| 2012 Q3 | -668.37 Million KRW | 0.0% |
| 2012 FY | -8.62 Billion KRW | 0.0% |
| 2012 Q4 | -6.1 Billion KRW | -812.68% |
| Name | Net Income | Net Income Difference |
|---|